185 related articles for article (PubMed ID: 27634463)
1. Pigmented lichenoid drug eruption: a new clinical presentation of interface dermatitis induced by anti-TNF alpha drugs.
Darrigade AS; Goussot JF; Milpied B; Taieb A; Seneschal J
Eur J Dermatol; 2016 Dec; 26(6):633-634. PubMed ID: 27634463
[No Abstract] [Full Text] [Related]
2. Exfoliative erythroderma after tumor necrosis factor-α inhibitor therapy.
el-Azhary RA; Lehman JS
Int J Dermatol; 2016 Apr; 55(4):e214-5. PubMed ID: 26917358
[No Abstract] [Full Text] [Related]
3. Paradoxical Autoinflammatory Skin Reaction to Tumor Necrosis Factor Alpha Blockers Manifesting as Amicrobial Pustulosis of the Folds in Patients With Inflammatory Bowel Diseases.
Marzano AV; Tavecchio S; Berti E; Gelmetti C; Cugno M
Medicine (Baltimore); 2015 Nov; 94(45):e1818. PubMed ID: 26559252
[TBL] [Abstract][Full Text] [Related]
4. Adalimumab-induced lichenoid drug eruption.
El Habr C; Meguerian Z; Sammour R
J Med Liban; 2014; 62(4):238-40. PubMed ID: 25807724
[TBL] [Abstract][Full Text] [Related]
5. Anti-Tumor Necrosis Factor-α-Induced Dermatological Complications in a Large Cohort of Inflammatory Bowel Disease Patients.
Andrade P; Lopes S; Gaspar R; Nunes A; Magina S; Macedo G
Dig Dis Sci; 2018 Mar; 63(3):746-754. PubMed ID: 29349693
[TBL] [Abstract][Full Text] [Related]
6. [Escitalopram, labial pigmentation and lichenoid eruption].
Schmutz JL; Barbaud A; Tréchot P
Ann Dermatol Venereol; 2008 Apr; 135(4):346. PubMed ID: 18420093
[No Abstract] [Full Text] [Related]
7. Psoriasiform Skin Lesions Are Caused by Both Infliximab and Adalimumab in a Patient with Crohn's Disease.
Cankurtaran E; Ekiz F; Hamamci M; Akinci H; Coskun Y; Yuksel I
Dig Dis Sci; 2016 Apr; 61(4):1206-7. PubMed ID: 26894400
[No Abstract] [Full Text] [Related]
8. Cutaneous drug eruption with an interface dermatitis pattern due to anti-tumour necrosis factor-alpha agents: a relevant class-effect.
Garcovich S; Burlando M; Rongioletti F; Garcovich A; Parodi A; Amerio P
Acta Derm Venereol; 2010 May; 90(3):311-2. PubMed ID: 20526559
[No Abstract] [Full Text] [Related]
9. Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-alpha antagonists.
Asarch A; Gottlieb AB; Lee J; Masterpol KS; Scheinman PL; Stadecker MJ; Massarotti EM; Bush ML
J Am Acad Dermatol; 2009 Jul; 61(1):104-11. PubMed ID: 19539844
[TBL] [Abstract][Full Text] [Related]
10. Lichenoid drug eruption induced by colchicine.
Akin Belli A; Mengi G; Dere Y; Dogan G
Dermatol Ther; 2016; 29(1):7-9. PubMed ID: 26439307
[No Abstract] [Full Text] [Related]
11. A mechanism-based classification of dermatologic reactions to biologic agents used in the treatment of cutaneous disease: Part 1.
Bremmer M; Deng A; Gaspari AA
Dermatitis; 2009; 20(4):182-92. PubMed ID: 19804694
[TBL] [Abstract][Full Text] [Related]
12. Solitary facial cutaneous chronic inflammatory lesions induced by anti-tumour necrosis factor-α antagonist.
Haro-Gabaldón V; Ruiz Molina I; Haro-González-Vico V; Solís García E
Clin Exp Dermatol; 2019 Jan; 44(1):80-82. PubMed ID: 30255515
[No Abstract] [Full Text] [Related]
13. Letter: Lichenoid eruption induced by etanercept.
Barrientos N; García-Sánchez S; Domínguez JD
Dermatol Online J; 2012 Jul; 18(7):15. PubMed ID: 22863637
[TBL] [Abstract][Full Text] [Related]
14. Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect.
Iborra M; Beltrán B; Bastida G; Aguas M; Nos P
J Crohns Colitis; 2011 Apr; 5(2):157-61. PubMed ID: 21453886
[TBL] [Abstract][Full Text] [Related]
15. Guillain-Barré syndrome in association with antitumour necrosis factor therapy: a case of mistaken identity.
Patwala K; Crump N; De Cruz P
BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28679512
[TBL] [Abstract][Full Text] [Related]
16. Clinical Pathologic Mismatch in a TNF-α Inhibitor-Associated Drug Reaction.
O’Brien KF; Maiman RE; DeWitt CA
J Drugs Dermatol; 2019 Aug; 18(8):828-830. PubMed ID: 31424716
[TBL] [Abstract][Full Text] [Related]
17. Are anti-TNF drugs safe for pregnant women with inflammatory bowel disease?
Brennan GT; Duong A; Nguyen ET; Nguyen DL
Cleve Clin J Med; 2018 Dec; 85(12):923-924. PubMed ID: 30526752
[No Abstract] [Full Text] [Related]
18. New Onset Autoimmune Hepatitis during Anti-Tumor Necrosis Factor-Alpha Treatment in Children.
Ricciuto A; Kamath BM; Walters TD; Frost K; Carman N; Church PC; Ling SC; Griffiths AM
J Pediatr; 2018 Mar; 194():128-135.e1. PubMed ID: 29274889
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous Pseudolymphoma in a Patient With Crohn's Disease Under Infliximab: First Report.
Carvalhana S; Gonçalves A; Velosa J
J Clin Gastroenterol; 2016; 50(5):436-7. PubMed ID: 26974759
[No Abstract] [Full Text] [Related]
20. Follicular eruption with folliculotropic lymphocytic infiltrates associated with anti-tumor necrosis factor alpha therapy: Report and study of 3 cases.
Avitan-Hersh E; Dias-Polak D; Ramon M; Zaaroura H; Sahar D; Bergman R
J Cutan Pathol; 2020 Feb; 47(2):113-120. PubMed ID: 31595531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
